{"id":"NCT04193189","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","briefTitle":"B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B","officialTitle":"B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-12-14","primaryCompletion":"2024-08-13","completion":"2024-08-13","firstPosted":"2019-12-10","resultsPosted":"2025-07-20","lastUpdate":"2025-07-20"},"enrollment":638,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["HIV Infection","Hepatitis B"],"interventions":[{"type":"BIOLOGICAL","name":"HEPLISAV-B","otherNames":[]},{"type":"BIOLOGICAL","name":"ENGERIX-B","otherNames":[]}],"arms":[{"label":"Group A, 2-CpG: HEPLISAV-B (two injections)","type":"EXPERIMENTAL"},{"label":"Group A, 3-CpG: HEPLISAV-B (three injections)","type":"EXPERIMENTAL"},{"label":"Group A, 3-alum: ENGERIX-B (three injections)","type":"ACTIVE_COMPARATOR"},{"label":"Group B: HEPLISAV-B (three injections)","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to evaluate response to and safety of the HBV vaccine HEPLISAV-B in two study populations of people living with HIV: prior HBV vaccine recipients who are deemed non-responders and individuals who are na√Øve to HBV vaccination.","primaryOutcome":{"measure":"Percentage of Participants With Primary Seroprotection Response","timeFrame":"Week 12 in Group A 2-CpG, Week 28 in Group A 3-CpG and 3-alum and in Group B","effectByArm":[{"arm":"Group A: 2-CpG","deltaMin":93.1,"sd":null},{"arm":"Group A: 3-CpG","deltaMin":99.4,"sd":null},{"arm":"Group A: 3-alum","deltaMin":80.6,"sd":null},{"arm":"Group B","deltaMin":100,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":15},"locations":{"siteCount":41,"countries":["United States","Botswana","Brazil","Kenya","Malawi","Philippines","South Africa","Thailand","Uganda","Vietnam"]},"refs":{"pmids":["37017075","39616603","40147293"],"seeAlso":["https://rsc.niaid.nih.gov/sites/default/files/daids-ae-grading-table-v2-nov2014.pdf","https://rsc.niaid.nih.gov/clinical-research-sites/manual-expedited-reporting-adverse-events-daids"]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":187},"commonTop":["Injection site pain","Headache","Fatigue","Malaise","Myalgia"]}}